{
    "relation": [
        [
            "Feature key",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti"
        ],
        [
            "Position(s)",
            "27 \u2013 27",
            "27 \u2013 27",
            "28 \u2013 28",
            "34 \u2013 34",
            "50 \u2013 50",
            "61 \u2013 61",
            "84 \u2013 84",
            "92 \u2013 92",
            "113 \u2013 113",
            "119 \u2013 119",
            "126 \u2013 126",
            "127 \u2013 127",
            "131 \u2013 131",
            "131 \u2013 131",
            "132 \u2013 132",
            "134 \u2013 134",
            "160 \u2013 160",
            "163 \u2013 163",
            "167 \u2013 167",
            "168 \u2013 168",
            "171 \u2013 171",
            "180 \u2013 180",
            "184 \u2013 184",
            "189 \u2013 189",
            "197 \u2013 197",
            "222 \u2013 222"
        ],
        [
            "Length",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1"
        ],
        [
            "Description",
            "P \u2192 H in Munster-3C. Corresponds to variant rs121912720 [ dbSNP | Ensembl ].",
            "P \u2192 R.1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.51 \"Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.\" von Eckardstein A., Funke H., Henke A., Altland K., Benninghoven A., Assmann G., Welp S., Roetrige A., Kock R. J. Clin. Invest. 84:1722-1730(1989) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ARG-27; ARG-28 AND ARG-189. Corresponds to variant rs121912720 [ dbSNP | Ensembl ].",
            "P \u2192 R in Munster-3B. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.51 \"Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.\" von Eckardstein A., Funke H., Henke A., Altland K., Benninghoven A., Assmann G., Welp S., Roetrige A., Kock R. J. Clin. Invest. 84:1722-1730(1989) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ARG-27; ARG-28 AND ARG-189.",
            "R \u2192 L in Baltimore. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.50 \"Apolipoprotein A1 Baltimore (Arg-10-->Leu), a new ApoA1 variant.\" Ladias J.A.A., Kwiterovich P.O. Jr., Smith H.H., Karathanasis S.K., Antonarakis S.E. Hum. Genet. 84:439-445(1990) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT BALTIMORE LEU-34. Corresponds to variant rs28929476 [ dbSNP | Ensembl ].",
            "G \u2192 R in AMYL8; also found in a family with amyloid polyneuropathy-nephropathy Iowa. 3 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.46 \"Variant apolipoprotein AI as a major constituent of a human hereditary amyloid.\" Nichols W.C., Dwulet F.E., Liepnieks J., Benson M.D. Biochem. Biophys. Res. Commun. 156:762-768(1988) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 25-107, VARIANT AMYL8 ARG-50. Ref.47 \"A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy.\" Nichols W.C., Gregg R.E., Brewer H.B. Jr., Benson M.D. Genomics 8:318-323(1990) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT AMYL8 ARG-50. Ref.54 \"Familial nephropathic systemic amyloidosis caused by apolipoprotein AI variant Arg26.\" Vigushin D.M., Gough J., Allan D., Alguacil A., Penner B., Pettigrew N.M., Quinonez G., Bernstein K., Booth S.E., Booth D.R., Soutar A.K., Hawkins P.N., Pepys M.B. Q. J. Med. 87:149-154(1994) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT AMYL8 ARG-50. Corresponds to variant rs28931574 [ dbSNP | Ensembl ].",
            "A \u2192 T.1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.10 \"The effects of scale: variation in the APOA1/C3/A4/A5 gene cluster.\" Fullerton S.M., Buchanan A.V., Sonpar V.A., Taylor S.L., Smith J.D., Carlson C.S., Salomaa V., Stengaard J.H., Boerwinkle E., Clark A.G., Nickerson D.A., Weiss K.M. Hum. Genet. 115:36-56(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT THR-61. Corresponds to variant rs12718465 [ dbSNP | Ensembl ].",
            "L \u2192 R in AMYL8. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.49 \"Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis.\" Soutar A.K., Hawkins P.N., Vigushin D.M., Tennent G.A., Booth S.E., Hutton T., Nguyen O., Totty N.F., Feest T.G., Hsuan J.J., Pepys M.B. Proc. Natl. Acad. Sci. U.S.A. 89:7389-7393(1992) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 25-112, VARIANT AMYL8 ARG-84.",
            "T \u2192 I Polymorphism; confirmed at protein level. 2 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.57 \"Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors.\" Morabia A., Cayanis E., Costanza M.C., Ross B.M., Flaherty M.S., Alvin G.B., Das K., Gilliam T.C. Hum. Mol. Genet. 12:2733-2743(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT ILE-92. Ref.58 \"Quantitative detection of single amino acid polymorphisms by targeted proteomics.\" Su Z.D., Sun L., Yu D.X., Li R.X., Li H.X., Yu Z.J., Sheng Q.H., Lin X., Zeng R., Wu J.R. J. Mol. Cell Biol. 3:309-315(2011) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT ILE-92, IDENTIFICATION BY MASS SPECTROMETRY.",
            "D \u2192 E.1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.52 \"Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure.\" von Eckardstein A., Funke H., Walter M., Altland K., Benninghoven A., Assmann G. J. Biol. Chem. 265:8610-8617(1990) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GLU-113; MET-131; GLY-163; VAL-171 AND LYS-222.",
            "A \u2192 D in Hita.",
            "D \u2192 H. Corresponds to variant rs5077 [ dbSNP | Ensembl ].",
            "D \u2192 N in Munster-3A.",
            "K \u2192 M.1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.52 \"Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure.\" von Eckardstein A., Funke H., Walter M., Altland K., Benninghoven A., Assmann G. J. Biol. Chem. 265:8610-8617(1990) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GLU-113; MET-131; GLY-163; VAL-171 AND LYS-222. Corresponds to variant rs4882 [ dbSNP | Ensembl ].",
            "Missing in Marburg/Munster-2.",
            "W \u2192 R in Tsushima.",
            "E \u2192 K in Fukuoka. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.48 \"Isolation and characterization of human apolipoprotein A-I Fukuoka (110 Glu-->Lys). A novel apolipoprotein variant.\" Takada Y., Sasaki J., Ogata S., Nakanishi T., Ikehara Y., Arakawa K. Biochim. Biophys. Acta 1043:169-176(1990) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 25-267, VARIANT FUKUOKA LYS-134.",
            "E \u2192 K in Norway. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.45 \"Abnormal lecithin:cholesterol acyltransferase activation by a human apolipoprotein A-I variant in which a single lysine residue is deleted.\" Rall S.C. Jr., Weisgraber K.H., Mahley R.W., Ogawa Y., Fielding C.J., Utermann G., Haas J., Steinmetz A., Menzel H.J., Assmann G. J. Biol. Chem. 259:10063-10070(1984) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT NORWAY LYS-160.",
            "E \u2192 G.1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.52 \"Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure.\" von Eckardstein A., Funke H., Walter M., Altland K., Benninghoven A., Assmann G. J. Biol. Chem. 265:8610-8617(1990) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GLU-113; MET-131; GLY-163; VAL-171 AND LYS-222.",
            "P \u2192 R in Giessen. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.44 \"Apolipoprotein A-IGiessen (Pro143-->Arg). A mutant that is defective in activating lecithin:cholesterol acyltransferase.\" Utermann G., Haas J., Steinmetz A., Paetzold R., Rall S.C. Jr., Weisgraber K.H., Mahley R.W. Eur. J. Biochem. 144:325-331(1984) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GIESSEN ARG-167.",
            "L \u2192 R in Zaragoza. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.56 \"Apo A-I Zaragoza(L144R): a novel mutation in the apolipoprotein A-I gene associated with familial hypoalphalipoproteinemia.\" Recalde D., Cenarro A., Civeira F., Pocovi M. Hum. Mutat. 11:416-416(1998) Cited for: VARIANT ZARAGOZA ARG-168.",
            "E \u2192 V.1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.52 \"Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure.\" von Eckardstein A., Funke H., Walter M., Altland K., Benninghoven A., Assmann G. J. Biol. Chem. 265:8610-8617(1990) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GLU-113; MET-131; GLY-163; VAL-171 AND LYS-222.",
            "V \u2192 E in Oita; 60% of normal apoA-I and normal HDL cholesterol levels. Rapidly cleared from plasma. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.55 \"A novel homozygous missense mutation in the apo A-I gene with apo A-I deficiency.\" Huang W., Sasaki J., Matsunaga A., Nanimatsu H., Moriyama K., Han H., Kugi M., Koga T., Yamaguchi K., Arakawa K. Arterioscler. Thromb. Vasc. Biol. 18:389-396(1998) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT AOITA GLU-180.",
            "R \u2192 P. Corresponds to variant rs5078 [ dbSNP | Ensembl ].",
            "P \u2192 R.1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.51 \"Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.\" von Eckardstein A., Funke H., Henke A., Altland K., Benninghoven A., Assmann G., Welp S., Roetrige A., Kock R. J. Clin. Invest. 84:1722-1730(1989) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ARG-27; ARG-28 AND ARG-189.",
            "R \u2192 C in Milano; no evidence of association with premature vascular disease; associated with decreased HDL levels and moderate increase in triglycerides; allows the formation of disulfide-linked homodimers via the introduced cysteine; assembles properly in HDL; alters protein structure; has no tendency to form fibrils and aggregates. 2 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.37 \"Secondary structure changes in ApoA-I Milano (R173C) are not accompanied by a decrease in protein stability or solubility.\" Petrlova J., Dalla-Riva J., Morgelin M., Lindahl M., Krupinska E., Stenkula K.G., Voss J.C., Lagerstedt J.O. PLoS ONE 9:E96150-E96150(2014) [PubMed] [Europe PMC] [Abstract] Cited for: CHARACTERIZATION OF VARIANT MILANO CYS-197. Ref.42 \"Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I.\" Weisgraber K.H., Rall S.C. Jr., Bersot T.P., Mahley R.W., Franceschini G., Sirtori C.R. J. Biol. Chem. 258:2508-2513(1983) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT MILANO CYS-197. Corresponds to variant rs28931573 [ dbSNP | Ensembl ].",
            "E \u2192 K in Munster-4. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.52 \"Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure.\" von Eckardstein A., Funke H., Walter M., Altland K., Benninghoven A., Assmann G. J. Biol. Chem. 265:8610-8617(1990) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GLU-113; MET-131; GLY-163; VAL-171 AND LYS-222."
        ],
        [
            "Graphical view",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
        ],
        [
            "Feature identifier",
            "VAR_000605",
            "VAR_000606",
            "VAR_000607",
            "VAR_000608",
            "VAR_000609",
            "VAR_025445",
            "VAR_000610",
            "VAR_017017",
            "VAR_000611",
            "VAR_000612",
            "VAR_016189",
            "VAR_000613",
            "VAR_000615",
            "VAR_000614",
            "VAR_000616",
            "VAR_000617",
            "VAR_000618",
            "VAR_000619",
            "VAR_000620",
            "VAR_000621",
            "VAR_000622",
            "VAR_021362",
            "VAR_014609",
            "VAR_000623",
            "VAR_000624",
            "VAR_000625"
        ],
        [
            "Actions",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
        ]
    ],
    "pageTitle": "APOA1 - Apolipoprotein A-I precursor - Homo sapiens (Human)",
    "title": "",
    "url": "http://www.uniprot.org/uniprot/P02647",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042986646.29/warc/CC-MAIN-20150728002306-00244-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 796380231,
    "recordOffset": 796313468,
    "tableOrientation": "HORIZONTAL",
    "TableContextTimeStampBeforeTable": "{9650=APOA1 mutations may be involved in the pathogenesis of amyloid polyneuropathy-nephropathy Iowa type, also known as amyloidosis van Allen type or familial amyloid polyneuropathy type III (PubMed:3142462 and PubMed:2123470). The clinical picture is dominated by neuropathy in the early stages of the disease and nephropathy late in the course. Death is due in most cases to renal amyloidosis.}",
    "lastModified": "Wed, 22 Jul 2015 00:00:00 GMT",
    "textBeforeTable": "Natural variant Genetic variations in APOA1 can result in APOA1 deficiency and are associated with low levels of HDL cholesterol [Online Mendelian Inheritance in Man (OMIM)<br/><a href='/database/62'>More..</a>MIMi:107680]. <p>Provides information on polymorphic variants. If the variant is associated with a disease state, the description of the latter can be found in the <a href=\"/manual/involvement_in_disease\">\u2018Involvement in disease\u2019</a> subsection.</p><p><a href='../manual/polymorphism' target='_top'>More...</a></p>Polymorphismi MASS SPECTROMETRY, OXIDATION AT MET-110 AND MET-136, TISSUE SPECIFICITY. Cited for: Abstract] Europe PMC] [ PubMed] [ J. Lipid Res. 44:349-355(2003) [ Stocker R. Raftery M., Panzenboeck U., Baernthaler G., Wilcken D.E., Wang X.L., Pankhurst G., \"Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein.\" Ref.32 <p>Manually curated information for which there is published experimental evidence.</p> <p><a href=\"/manual/evidences#ECO:0000269\">More\u2026</a></p> Manual assertion based on experiment ini 1 Publication ESI. With 2 methionine sulfoxides, oxidation at Met-110 and Met-136. 25 - 267. Determined by Da from positions Molecular mass is 28114 MASS SPECTROMETRY, OXIDATION",
    "textAfterTable": "Sequence databases Select the link destinations: EMBL nucleotide sequence database<br/><a href='/database/22'>More..</a>EMBLi GenBank nucleotide sequence database<br/><a href='/database/28'>More..</a>GenBanki DNA Data Bank of Japan; a nucleotide sequence database<br/><a href='/database/14'>More..</a>DDBJi Links Updated J00098 Genomic DNA. Translation: AAB59514.1. X01038 Genomic DNA. Translation: CAA25519.1. X02162 mRNA. Translation: CAA26097.1. X00566 mRNA. Translation: CAA25232.1. M11791 mRNA. Translation: AAA35545.1. X07496 Genomic DNA. Translation: CAA30377.1. M27875 mRNA. Translation: AAA62829.1. M29068 mRNA. Translation: AAA51747.1. AY422952 Genomic DNA. Translation: AAQ91811.1. AY555191 Genomic DNA. Translation: AAS68227.1. A14829 mRNA. Translation: CAA01198.1. AK292231 mRNA. Translation:",
    "hasKeyColumn": false,
    "keyColumnIndex": -1,
    "headerRowIndex": 0
}